A Ganser, O G Ottmann, G Seipelt, M Eder, G Geissler, R Merget, A Maurer, S Falk, A Lindemann, F Herrmann
{"title":"重组人白细胞介素-3的I/II期试验结果。","authors":"A Ganser, O G Ottmann, G Seipelt, M Eder, G Geissler, R Merget, A Maurer, S Falk, A Lindemann, F Herrmann","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":77042,"journal":{"name":"Biotechnology therapeutics","volume":"2 3-4","pages":"313-25"},"PeriodicalIF":0.0000,"publicationDate":"1991-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Results of phase I/II trials with recombinant human interleukin-3.\",\"authors\":\"A Ganser, O G Ottmann, G Seipelt, M Eder, G Geissler, R Merget, A Maurer, S Falk, A Lindemann, F Herrmann\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":77042,\"journal\":{\"name\":\"Biotechnology therapeutics\",\"volume\":\"2 3-4\",\"pages\":\"313-25\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotechnology therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology therapeutics","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0